Medullary thyroid cancer and Constipation

Summary:

Constipation is found among people with Medullary thyroid cancer, especially for people who are female, 60+ old.

The study analyzes which people have Constipation with Medullary thyroid cancer. It is created by eHealthMe based on reports of 38 people who have Medullary thyroid cancer from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Medullary thyroid cancer?

Medullary thyroid cancer (type of thyroid cancer that develops in the parafollicular cells of the thyroid gland) is found to be associated with 28 drugs and 74 conditions by eHealthMe. Check the latest studies of Medullary thyroid cancer.

What is Constipation?

Constipation is found to be associated with 3,004 drugs and 4,614 conditions by eHealthMe. Check the latest studies of Constipation.



On Jul, 25, 2026

38 people who have Medullary Thyroid Cancer and Constipation are studied.

Would you have Constipation when you have Medullary thyroid cancer?

Gender of people who have Medullary Thyroid Cancer and experienced Constipation *:

  • female: 85.71 %
  • male: 14.29 %

Age of people who have Medullary Thyroid Cancer and experienced Constipation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 3.23 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25.81 %
  • 50-59: 29.03 %
  • 60+: 41.94 %

Common co-existing conditions for these people *:

  1. Diarrhea: 7 people, 18.42%
  2. Inflammation: 2 people, 5.26%
  3. High Blood Pressure: 2 people, 5.26%
  4. Metastases To Liver (cancer spreads to liver): 1 person, 2.63%
  5. Metastases To Bone (cancer spreads to bone): 1 person, 2.63%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 2.63%
  7. Carcinoid Tumor: 1 person, 2.63%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 2.63%

Common drugs taken by these people *:

  1. Synthroid: 22 people, 57.89%
  2. Calcium: 20 people, 52.63%
  3. Pantoprazole: 15 people, 39.47%
  4. Sutent: 10 people, 26.32%
  5. Dilaudid: 9 people, 23.68%
  6. Betaderm: 7 people, 18.42%
  7. Rocaltrol: 7 people, 18.42%
  8. Xarelto: 6 people, 15.79%
  9. Caprelsa: 6 people, 15.79%
  10. Fragmin: 6 people, 15.79%

Common symptoms for these people *:

  1. Diarrhea: 24 people, 63.16%
  2. Fatigue (feeling of tiredness): 21 people, 55.26%
  3. Nausea And Vomiting: 12 people, 31.58%
  4. High Blood Pressure: 11 people, 28.95%
  5. Dyspnea (difficult or laboured breathing): 10 people, 26.32%
  6. Anal Haemorrhage: 9 people, 23.68%
  7. Nausea (feeling of having an urge to vomit): 9 people, 23.68%
  8. Hair Loss: 8 people, 21.05%
  9. Anal Injury: 8 people, 21.05%
  10. Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 8 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Constipation?

- Check whether Constipation is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Constipation:

All the conditions that are associated with Constipation:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Constipation and Medullary thyroid cancer, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: